Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06830746 · ClinicalTrials.gov registry record · NA
ASCEND CSP IDE Study
A NA study of Heart Failure and Ventricular Arrythmia, sponsored by Abbott Medical Devices.
- Active
- Registry status
- NA
- Development phase
- 414
- Enrollment target
- 20
- Study locations
NCT06830746 is a NA study of Heart Failure and Ventricular Arrythmia that is active but no longer recruiting, run by Abbott Medical Devices. The registered enrollment target is 414 participants, below the 2,048-participant average among 397 other Heart Failure trials with a reported enrollment target (80% lower). The trial reports 20 study locations across 16 states.
The verdict
NCT06830746, a NA study of Heart Failure and Ventricular Arrythmia, is active but no longer recruiting, sponsored by Abbott Medical Devices.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 414 participants
- Enrollment target
- 20
- Study locations
Study Summary
This is a prospective, multi-center, global, single-arm, pivotal investigational study designed to evaluate the safety and effectiveness of the CSP ICD Lead in a subject population indicated for ICD or CRT-D therapy. The clinical investigation will enroll up to 414 subjects at up to 70 participating centers from the United States, Canada, Europe, and Asia Pacific.
Conditions Studied
Interventions
- DEVICE LBBAP Implant with a CSP ICD Lead
Study Locations (20)
Pennsylvania
- Geisinger Medical Center - Danville
- Lancaster General Hospital - Lancaster
- Hospital of the University of Pennsylvania - Philadelphia
California
- Premier Cardiology, Inc. - Newport Beach
- University of California at San Diego (UCSD) Medical Center - San Diego
Queensland
- The Prince Charles Hospital - Chermside
- Princess Alexandra Hospital - Woolloongabba
Alabama
- Heart Center Research LLC - Huntsville
Arizona
- Banner University Medical Center Phoenix - Phoenix
Arkansas
- Arrhythmia Research Group - Jonesboro
District of Columbia
- MedStar Washington Hospital Center - Washington D.C.
Florida
- AdventHealth Orlando - Orlando
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 414 participants |
| Start Date | 2025-04-11 |
| Est. Completion | 2028-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06830746
The ClinicalTrials.gov registry entry for NCT06830746 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 414 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,048-participant average among 397 other Heart Failure trials with a reported enrollment target (80% lower). The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which LBBAP Implant with a CSP ICD Lead is the first listed.
NCT06830746 reports 20 study locations spanning 16 distinct geographic areas - top geographies include Pennsylvania, California, Queensland.
Frequently Asked Questions
What is clinical trial NCT06830746 about?
NCT06830746 is a clinical study titled "ASCEND CSP IDE Study". This is a prospective, multi-center, global, single-arm, pivotal investigational study designed to evaluate the safety and effectiveness of the CSP ICD Lead in a subject population indicated for ICD or CRT-D therapy. The clinical investigation will enroll up to 414 subjects at up to 70 participatin...
What is the current status of trial NCT06830746?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 414 participants. The study started on 2025-04-11. Estimated completion is 2028-05.
What conditions does trial NCT06830746 study?
This clinical trial studies the following conditions: Heart Failure, Ventricular Arrythmia.
What interventions are being tested in trial NCT06830746?
The interventions under investigation include: LBBAP Implant with a CSP ICD Lead (DEVICE).
Who is sponsoring clinical trial NCT06830746?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06830746 being conducted?
This trial has 20 study locations across Alabama, Arizona, Arkansas, California, District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.